Introduction {#s1}
============

Apnea and its accompanying arterial O~2~ desaturation are common clinical complications in preterm infants, occurring in more than 50% of very low birth weight infants [@pcbi.1000588-Barrington1]. In preterm infants, apnea causes a reduction in heart rate [@pcbi.1000588-Poets1] and cerebral perfusion [@pcbi.1000588-Perlman1], often requires mechanical ventilation, and is associated with neurodevelopmental impairment [@pcbi.1000588-Janvier1]. Apnea-related hypoxemia is of major concern in light of evidence that repetitive hypoxia in newborn animals results in irreversibly-altered carotid body function [@pcbi.1000588-Prabhakar1], raising the possibility of impaired ventilatory control, and causes neurocognitive and behavioural deficits [@pcbi.1000588-Row1]. Respiratory arrest and hypoxemia are also strongly implicated in sudden infant death syndrome (SIDS) [@pcbi.1000588-Kato1],[@pcbi.1000588-Naeye1] where the speed at which hypoxemia develops is considered to be particularly dangerous.

In preterm infants, the rate of arterial O~2~ desaturation () can be highly variable and rapid, with average rates as high as 4.3% s^−1^ during isolated apneas [@pcbi.1000588-Poets2]. An earlier framework to describe proposed that metabolic O~2~ consumption relative to alveolar volume determines the speed at which alveolar falls [@pcbi.1000588-Fletcher1]; it was envisaged that is then a function of falling and the slope of the oxy-hemoglobin dissociation curve. However, such a model assumes that the rate of alveolar depletion of O~2~, denoted pulmonary O~2~ uptake (), is equal to tissue O~2~ consumption during apnea (see [Methods](#s4){ref-type="sec"} -- Theory). Previous studies in adults have shown that falls from metabolic consumption during apnea [@pcbi.1000588-Lanphier1], and our previous modeling studies in lambs showed that the difference between and metabolic O~2~ consumption has a crucial role in determining during recurrent apneas [@pcbi.1000588-Wilkinson1]. We found that apneic changes in cause desaturation to occur in 2 stages. During stage 1, lung O~2~ stores are depleted, and falls below metabolic consumption. During stage 2, is close to zero, and tissue O~2~ needs are provided by depletion of blood O~2~ stores.

To date, no complete theoretical analysis of the factors influencing desaturation during apnea has been published. The only available study [@pcbi.1000588-Farmery1] has a number of critical limitations. First, the model incorporated a constraint of a fixed difference between and mixed-venous saturation; thus dynamic changes in could not occur and their influence on could not be examined. Second, no assessment was made of the impact of cardiorespiratory factors on the two stages of O~2~ desaturation. Third, in focusing on adults, the study did not examine profound desaturation to levels well below 60% as can often occur in preterm infants [@pcbi.1000588-Poets2],[@pcbi.1000588-Poets3].

Accordingly, the aim of the current study was to quantify the importance of cardiorespiratory factors relevant to during apnea, with particular reference to the preterm infant. Using a model that permits variation of during apnea, we examine a number of factors known to influence , such as lung volume [@pcbi.1000588-Poets4], metabolic O~2~ consumption [@pcbi.1000588-HendersonSmart1] and pre-apneic arterial oxygenation [@pcbi.1000588-Strohl1] as well as factors that are particularly pertinent for the developing newborn, including anemia, hypovolemia, reduced O~2~ affinity, and chronically and acutely reduced cardiac output. We use the results to develop a conceptual framework for the interpretation of mechanisms underlying rapid during apnea.

Results {#s2}
=======

Overview of the two-compartment model for gas exchange {#s2a}
------------------------------------------------------

To determine the independent influence of clinically relevant cardiorespiratory factors on during a single isolated apnea, we used a two-compartment lung-body mathematical model which incorporated realistic blood O~2~ stores and gas exchange dynamics ([Figure 1](#pcbi-1000588-g001){ref-type="fig"}), as described in [Methods](#s4){ref-type="sec"} -- Mathematical model (a full list of symbols is provided in [Table 1](#pcbi-1000588-t001){ref-type="table"}). We used published parameters for healthy preterm infants born at ∼30 wk gestational age ([Table 2](#pcbi-1000588-t002){ref-type="table"}); the values represent measurements taken at approximately term equivalent age when surprisingly rapid desaturation has been observed [@pcbi.1000588-Poets2]. We also derive analytic solutions for to quantify the importance of cardiorespiratory factors on to obtain a detailed view of the arterial O~2~ desaturation process, as described in [Methods](#s4){ref-type="sec"} -- Theory.

![Model schematic representing O~2~ uptake, transport and consumption.\
O~2~ stores are represented by the alveolar, arterial, and venous compartments. Two dynamically-independent levels of O~2~ uptake are denoted: pulmonary O~2~ uptake () and metabolic consumption (). R-L shunt is also included. T~a~ is the arterial transit time. Symbols are described in [Table 1](#pcbi-1000588-t001){ref-type="table"}.](pcbi.1000588.g001){#pcbi-1000588-g001}
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###### Mathematical symbols.

![](pcbi.1000588.t001){#pcbi-1000588-t001-1}

  Symbol                                                          Description
  -------- -------------------------------------------------------------------------------------------------------------------------
                                                            Arterial CO~2~ content
                                                             Arterial O~2~ content
                                                     End-capillary arterial CO~2~ content
                                                      End-capillary arterial O~2~ content
                                                          Mixed venous CO~2~ content
                                                           Mixed venous O~2~ content
                                                 Rate of change in mixed venous CO~2~ content
                                                  Rate of change in mixed venous O~2~ content
                                                           Fractional inspired O~2~
                                                        R-L pulmonary shunt fraction ()
                                                          Hemoglobin content of blood
                                      Barometric pressure, including conversion from STP to BTP, 863 mmHg
                                                    O~2~ partial pressure at 50% saturation
                                                             O~2~ partial pressure
                                                        Arterial CO~2~ partial pressure
                                                        Arterial O~2~ partial pressure
                                                        Alveolar CO~2~ partial pressure
                                                        Alveolar N~2~ partial pressure
                                                        Alveolar O~2~ partial pressure
                                                Alveolar water vapour partial pressure, 47 mmHg
                                                         Barometric pressure, 760 mmHg
                                                     End-capillary CO~2~ partial pressure
                                                      End-capillary O~2~ partial pressure
                                                        Inspired CO~2~ partial pressure
                                                        Inspired N~2~ partial pressure
                                                        Inspired O~2~ partial pressure
                                                      Mixed venous O~2~ partial pressure
                                                      Mixed venous CO~2~ partial pressure
                                               Rate of change in alveolar CO~2~ partial pressure
                                               Rate of change in alveolar N~2~ partial pressure
                                               Rate of change in alveolar O~2~ partial pressure
                                                                Arterial volume
                                                                 Blood volume
                                                            Blood volume for CO~2~
                                                             Blood volume for O~2~
                                                          Venous (and tissue) volume
                                                     Venous (and tissue) volume for CO~2~
                                                      Venous (and tissue) volume for O~2~
                                                                Cardiac output
                                                             Pulmonary blood flow
                                                         Respiratory exchange ratio ()
                                                                O~2~ saturation
                                                           Arterial O~2~ saturation
                                                    End-capillary arterial O~2~ saturation
                                                         Mixed venous O~2~ saturation
                                                      Rate of arterial O~2~ desaturation
                                                     Average from t = 0--10 s during apnea
                                              Peak instantaneous ('linear') during apnea; stage 1
                                                                during stage 2
                                                    Rate of mixed-venous O~2~ desaturation
                                                             Arterial transit time
                                                                  Lung volume
                                                          Metabolic CO~2~ production
                                                          Metabolic O~2~ consumption
                                                         Expired alveolar ventilation
                                                         Inspired alveolar ventilation
                                              Pulmonary CO~2~ uptake (from capillary to alveoli)
                                               Pulmonary O~2~ uptake (from alveoli to capillary)
                                              Net pulmonary gas uptake from alveoli to capillary
                                                  Capacitance co-efficient of blood for CO~2~
                                 Capacitance co-efficient of blood for O~2~ relating changes in to changes in
            Capacitance co-efficient of hemoglobin for O~2~; slope of the O~2~-dissociation curve relating changes in to changes in

10.1371/journal.pcbi.1000588.t002

###### Typical parameters for the preterm infant at term equivalent age.

![](pcbi.1000588.t002){#pcbi-1000588-t002-2}

  Parameter                                Value                                      Reference/s
  ------------------------------- ----------------------- -------------------------------------------------------------------
  Lung volume ()                       20 ml kg^−1^              [@pcbi.1000588-Hjalmarson1],[@pcbi.1000588-Hulskamp1]
  Metabolic O~2~ consumption ()    10 ml min^−1^ kg^−1^    [@pcbi.1000588-Hill2],[@pcbi.1000588-Hey1],[@pcbi.1000588-Bauer1]
  Cardiac output ()                250 ml min^−1^ kg^−1^                       [@pcbi.1000588-Walther1]
  Hemoglobin content (Hb)               8 g dl^−1^                      [@pcbi.1000588-DelivoriaPapadopoulos1]
  P~50~                                   24 mmHg                       [@pcbi.1000588-DelivoriaPapadopoulos1]
  Blood volume ()                      80 ml kg^−1^                           [@pcbi.1000588-Linderkamp1]

P~50~ is the partial pressure at 50% saturation. is taken from data on functional residual capacity. For all simulations unless otherwise stated: respiratory exchange ratio (RER) was assumed to be 0.8; shunt fraction (Fs) was adjusted to 8.7% to achieve a resting of 72 mmHg as is typical for normal healthy infants [@pcbi.1000588-Koch1]; resting alveolar ventilation ( under normal conditions) was set to achieve resting .

Pulmonary gas exchange dynamics during apnea {#s2b}
--------------------------------------------

To examine changes in O~2~/CO~2~ exchange during apnea, a single apnea was imposed on the model. During apnea, changes in alveolar O~2~ and CO~2~ stores are not constant ([Figure 2](#pcbi-1000588-g002){ref-type="fig"}); importantly, alveolar () did not continue to fall at its initial rate as governed by metabolic O~2~ consumption (), but instead the rate of fall in was reduced as it approached mixed venous (), an observation also reflected in the falling . As a result, two distinct phases for O~2~ depletion can be seen, which we refer to as stage 1 and stage 2 [@pcbi.1000588-Wilkinson1]. During stage 1, fell rapidly and decreased and became dissociated from ; during stage 2, with greatly reduced, both and fell together at a reduced rate. The two distinct phases were also observed for alveolar and arterial (, ) although stage 1 for CO~2~ was substantially shorter than that for O~2~. Such an effect results from the earlier fall in pulmonary CO~2~ uptake () relative to the fall in ([Figure 2A](#pcbi-1000588-g002){ref-type="fig"}) and is reflected in the reduction in respiratory exchange ratio () ([Figure 2B](#pcbi-1000588-g002){ref-type="fig"}). Consequently, a more rapid fall in was observed compared with the rise in (see [Methods](#s4){ref-type="sec"} -- Derivation of equations), such that fell by 100 mmHg in the time rose by just 14 mmHg ([Figure 2C](#pcbi-1000588-g002){ref-type="fig"}).

![Pulmonary gas exchange during apnea.\
(A) Rate of pulmonary O~2~/CO~2~ exchange. and fall from resting levels during apnea. (B) Net alveolar-capillary gas uptake () and respiratory exchange ratio ()during apnea. (C) Changes in alveolar, arterial and mixed venous during apnea. Contrast the time-course in and as they fall/rise towards . (\*) represents the fall in if was assumed equal to . S1 = stage 1; S2 = stage 2.](pcbi.1000588.g002){#pcbi-1000588-g002}

Time-course of during apnea {#s2c}
---------------------------

The time-course of is complex ([Figure 3](#pcbi-1000588-g003){ref-type="fig"}), a consequence of the nonlinear O~2~-dissociation curve in combination with the fall in . At apnea onset, started to fall with a rate equivalent to that predicted by Equation 12, where ([Figure 3](#pcbi-1000588-g003){ref-type="fig"}). During apnea, changes in the slope of the O~2~-dissociation curve () and dominated the time-course of desaturation as hypoxemia progressed. As started to fall after apnea onset, increased with little change in , resulting in a proportional increase in . However, as arterial hypoxemia developed, there was a concurrent decline in . As is directly proportional to the product (Equation 11) it follows that during apnea, the peak of 3.5% s^−1^ occurred when reached a maximum. This occurred when neither nor was at its maximum (both ∼50% of peak). Finally, with greatly reduced during stage 2, remained at a constant level (), close to that predicted by Equation 13 (1.8% s^−1^).

![The time course of during apnea.\
Panel (A) shows the increase in the slope of the oxy-hemoglobin dissocation curve at the level of alveolar (), and the fall in pulmonary oxygen uptake () that occurs during apnea. Panel (B) shows that changes in the product explain the time course of the instantaneous slope of arterial O~2~ desaturation () during apnea. Note that the peak occurs when is substantially less than its resting value. Note also that the rate of fall of mixed-venous saturation () and become equal and constant after 20 s.](pcbi.1000588.g003){#pcbi-1000588-g003}

Factors influencing {#s2d}
-------------------

The following parameters were individually varied from their 'normal' values to quantify their influence on : resting , lung volume (), metabolic O~2~ consumption (), blood hemoglobin content (Hb), cardiac output (), R-L shunt fraction (Fs), and the at 50% saturation (P~50~). All other parameters were kept constant to remove confounding effects, unless specified otherwise.

To quantify we used 3 different measures. First, since apnea is considered clinically significant if it lasts for \>10 s and is accompanied by bradycardia or O~2~ desaturation [@pcbi.1000588-Finer1], we calculated the average rate of fall in between apnea onset and 10 s later (); such a measure describes the immediacy of onset of desaturation and is analogous to the practical measurement of average used in many clinical studies [@pcbi.1000588-Poets2],[@pcbi.1000588-Poets4],[@pcbi.1000588-Upton1],[@pcbi.1000588-Adams1]. Second, we determined the peak instantaneous during apnea (), the value during the linear portion of arterial desaturation [@pcbi.1000588-Fletcher1],[@pcbi.1000588-Stewart1] which we find is not confounded by resting . Third, we report a measure of during stage 2 apnea (). To quantify the sensitivity of to changes in each cardiorespiratory factor, we defined the term impact ratio as the ratio of proportional increase in to a small increase from the normal value of each factor. For example, an impact ratio of 1 indicates a one-to-one increase in with an increase in the factor, and a negative ratio indicates an inverse relationship. The impact of each cardiorespiratory factor on , , and is summarised in [Table 3](#pcbi-1000588-t003){ref-type="table"}.

10.1371/journal.pcbi.1000588.t003

###### Impact ratios describing the effect of cardiorespiratory factors on .

![](pcbi.1000588.t003){#pcbi-1000588-t003-3}

  Parameter alteration                            
  ------------------------------- ------- ------- -------
  Resting                          −3.97   −0.35   −0.01
  Lung volume (VL)                 −2.24   −0.82   −0.09
  Blood volume (Qb)                −0.01   −0.06   −0.68
  O~2~ consumption () ^CC^         +2.29   +1.00   +1.00
  O~2~ consumption () ^nCC^        +2.73   +1.92   +1.00
  Hemoglobin content (Hb) ^nCC^    −0.38   −1.00   −0.89
  Hemoglobin content (Hb) ^CC^     +0.01   −0.10   −0.89
  P~50~                            +1.37   −0.68   −0.11
  Cardiac output (, resting)       −0.39   −0.90   0.00
  Cardiac output (, transient)     +1.45   −0.06   0.00
  Shunt Fraction (Fs)              −0.01   +0.01   0.00

Impact ratio is defined as the ratio of proportional increase in to the proportional increase in each factor, based on small changes around normal values. An impact ratio of 1 indicates a one-to-one increase in \>with an increase in the factor, and a negative ratio indicates an inverse relationship. CC = cardiac compensated, nCC = cardiac uncompensated.

### Resting {#s2d1}

Changes in , achieved via reduced resting ventilation or increasing inspired O~2~ (), had a substantial effect on the onset of desaturation. Reduced pre-apneic dramatically increased ([Figure 4A](#pcbi-1000588-g004){ref-type="fig"}), but had little effect on or . In contrast, increasing pre-apneic with the application of supplemental O~2~ achieved the opposite, essentially right-shifting or delaying the arterial desaturation curve, where one second of delay can be achieved by an increase in () of ∼7 mmHg, or of ∼1% (see [Methods](#s4){ref-type="sec"} -- Derivation of equations). These results occurred despite only a minor influence being visible on resting . For example, a reduction of from 100 to 60 mmHg caused a 6% reduction in resting but at the same time led to a more than 2-fold elevation in ([Figure 4B](#pcbi-1000588-g004){ref-type="fig"}). Additionally, a severe reduction in , to below 70 mmHg, was required to elevate .

![Impact of pre-apneic alveolar (ventilation, supplemental O~2~) on .\
(A) Effect of three levels of alveolar (), (i) 100 mmHg, (ii) 80 mmHg and (iii) 60 mmHg, on arterial () and mixed venous () O~2~ desaturation during apnea. Note that arterial O~2~ desaturation is substantially right-shifted with increased . (B) Sensitivity of to changes in pre-apneic (). Note that reduced has a major impact on but little impact on ; the influence on is small in the normal range but becomes stronger at low . n = 'normal' \'values; S1, stage 1 slope; S2, stage 2 slope.](pcbi.1000588.g004){#pcbi-1000588-g004}

### Lung volume (VL) and blood volume (Qb) {#s2d2}

and were inversely related to VL during stage 1 ([Figure 5A, B](#pcbi-1000588-g005){ref-type="fig"}), but changes in VL had no influence on . In direct contrast, reduced Qb strongly increased , but had no effect on stage 1 desaturation as reflected in no change in or ([Figure 5C, D](#pcbi-1000588-g005){ref-type="fig"}).

![Impact of lung volume (VL) and blood volume (Qb) on .\
(A) Effect of three levels of VL, (i) 30, (ii) 20 and (iii) 10 ml kg^−1^, on arterial () and mixed venous () O~2~ desaturation during apnea. (B) Sensitivity of to changes in V~L~. Note that reduced V~L~ has a strong impact on and but no impact on . (C) Effect of three levels of Qb, (iv) 120, (v) 80 and (iv) 40 ml kg^−1^, on and during apnea. (D) Sensitivity of to changes in Qb. Note that reduced Qb has little impact on or but has a large impact on . n = 'normal' values; S1, stage 1 slope; S2, stage 2 slope.](pcbi.1000588.g005){#pcbi-1000588-g005}

### Metabolic O~2~ consumption () {#s2d3}

To examine the impact of changing on , independent of resting , was adjusted to maintain resting constant, where ; we refer to this procedure as 'cardiac compensation'. Under this condition, elevated caused a directly proportional increase in throughout stages 1 and 2 ([Figure 6A, B](#pcbi-1000588-g006){ref-type="fig"}). Without cardiac compensation, the effect of increased on during stage 1 was magnified, as shown by the further increase in ([Figure 6A, B](#pcbi-1000588-g006){ref-type="fig"}).

![Impact of metabolic O~2~ consumption () on .\
Panel (A) shows the effect of doubling on arterial () and mixed venous () O~2~ during apnea; (i) 10 ml min^−1^kg^−1^, (ii) 20 ml min^−1^kg^−1^ with cardiac compensation (CC), and (iii) 20 ml min^−1^kg^−1^ with no CC (nCC). Note that with CC, increased , from (i) to (ii), elevated uniformly at all levels of during both stages 1 and 2; note that the level of at the inflection point (shown by short black lines) is unchanged. With nCC (iii), increased caused a reduced resting and lower inflection, and greater during stage 1, compared to (ii). (B) Sensitivity of to changes in . Note that with increased : a uniform increase in occurred with CC, and a more-than-proportional increase was seen with nCC; is elevated in both cases, but more so with nCC; a uniform increase in is shown regardless of CC. n = 'normal' values; S1, stage 1 slope; S2, stage 2 slope.](pcbi.1000588.g006){#pcbi-1000588-g006}

### Hemoglobin content (Hb) and oxygen affinity (P~50~) {#s2d4}

Reduced hemoglobin content (Hb) increased and but had little effect on ([Figure 7A, B](#pcbi-1000588-g007){ref-type="fig"}). The increase in occurred with an increase in the peak of the product as was higher at each level of . The simulation was repeated with cardiac compensation for the reduction in hemoglobin content, where , to maintain constant resting . Following such compensation, no changes in or were observed but reduced Hb continued to increase . In examining the influence of P~50~, P~90~ was adjusted in equal proportion on the basis of published data [@pcbi.1000588-DelivoriaPapadopoulos1]. Increased P~50~ increased the immediate , increased , decreased and had no effect on ([Figure 7C, D](#pcbi-1000588-g007){ref-type="fig"}).

![Impact of hemoglobin content (Hb) and O~2~ affinity (P~50~) on .\
(A) Effect of three levels of Hb, (i) 12 g dl^−1^, (ii) 8 g dl^−1^ and (iii) 4 g dl^−1^, on arterial () and mixed venous () O~2~ desaturation during apnea. Note the fall in at the inflection point (shown by short black lines). Note also that the reduced Hb has little impact on desaturation above . (B) Sensitivity of to changes in Hb. (C) Effect of three levels of P~50~, (iv) 18 mmHg, (v) 24 mmHg, and (vi) 36 mmHg, on . (D) Sensitivity of to changes in P~50~. n = 'normal' values; S1, stage 1 slope; S2, stage 2 slope.](pcbi.1000588.g007){#pcbi-1000588-g007}

### Cardiac output () {#s2d5}

Reduced resting increased , but had little impact on or ([Figure 8A, B](#pcbi-1000588-g008){ref-type="fig"}). As with Hb, the increase in with reduced resting occurred with an increase in the peak of the product . To differentiate between the influence on of an acute reduction in cardiac output, i.e. when bradycardia accompanies apnea, rather than a chronic reduction, we reduced cardiac output in a step-wise manner from the baseline value at the time of apnea onset. In constrast to the effect of reduced resting , a transient reduction in decreased , but had a negligible impact on or ([Figure 8C, D](#pcbi-1000588-g008){ref-type="fig"}).

![Impact of cardiac output () on .\
(A) Effect of three levels of resting , (i) 375 ml min^−1^kg^−1^, (ii) 250 ml min^−1^kg^−1^, and (iii) 125 ml min^−1^kg^−1^, on arterial () and mixed venous () O~2~ during apnea. Note that reduced elevates , associated with a reduction in resting and reduction in at the stage 1--2 transition or inflection point (shown by short black lines). (B) Sensitivity of to changes in . Note the strong influence of on , but negligible effect on and . (C) Simulations in (A) repeated for a step change in at apnea onset by (iv) +125 ml min^−1^kg^−1^ (e.g. tachycardia), (v) 0 ml min^−1^kg^−1^, and (vi) −125 ml min^−1^kg^−1^ (e.g. bradycardia), following resting . Note that the transient effect of is opposite to the resting effect of on arterial desaturation during apnea. (D) Sensitivity of to acute changes in during apnea. Note the strong influence of a step-change in on , but negligible effect on and . n = 'normal' values.](pcbi.1000588.g008){#pcbi-1000588-g008}

### Resting R-L shunt fraction (Fs) {#s2d6}

Increased Fs reduced resting and but had no effect on , , or ([Figure 9A, B](#pcbi-1000588-g009){ref-type="fig"}).

![Impact of R-L shunt (Fs) on .\
(A) Effect of three levels of Fs, (i) 0%, (ii) 15%, and (iii) 30%, on arterial () and mixed venous () O~2~ during apnea. Note that resting R-L shunt fraction has a negligible impact on during apnea. (B) Sensitivity of to changes in Fs. n = 'normal' values; S1, stage 1 slope; S2, stage 2 slope.](pcbi.1000588.g009){#pcbi-1000588-g009}

Discussion {#s3}
==========

Our model analysis of the rate of arterial O~2~ desaturation during apnea demonstrates that pre-apneic ventilation, lung volume, cardiac output, hemoglobin content and blood volume exert unique effects on throughout the time-course of desaturation, while metabolic O~2~ consumption is uniformly influential throughout the process. Our analysis reveals that lung volume and the slope of the O~2~-dissociation curve are important early in the process, during what we refer to as stage 1 [@pcbi.1000588-Wilkinson1], but not stage 2. For the first time, our study reveals that reduced cardiac output and hemoglobin content, and as a consequence resting mixed-venous saturation, substantially accelerate peak . Finally, low blood volume and hemoglobin content, and therefore a low total blood O~2~ capacity, increase the speed of desaturation, but only in stage 2. In addition to infants with elevated metabolic needs and low lung volume, those with anemia, cardiac dysfunction, or hypovolemia, which are common complications of prematurity, are at heightened risk of rapid and profound arterial desaturation during apnea.

Methodological considerations {#s3a}
-----------------------------

To evaluate the independent effects of cardiorespiratory factors on we used a two-compartment model, incorporating both alveolar and blood gas stores. The inclusion of a realistic blood store was crucial to reveal that changes in occur as a consequence of arterial and mixed-venous saturation falling asynchronously during apnea ([Figure 3](#pcbi-1000588-g003){ref-type="fig"}). Our approach allowed us to extend the previous framework based on the assumption of constant [@pcbi.1000588-Fletcher2], which prevented the recognition that a steep O~2~-dissociation curve and low lung volume do not accelerate beyond stage 1. Furthermore, the varying permitted recognition that cardiac output, hemoglobin content, and blood volume have a major influence on .

In the current study, the typical value of found using our model was 3.5% s^−1^ whereas Poets and Southall [@pcbi.1000588-Poets2] using beat-by-beat oximetry in preterm infants reported a mean value for during isolated apneas. Reasons for our lower value may lie with our simplifying assumptions. Notably, we assumed a homogenous lung compartment and complete gas mixing and as such, the model incorporated neither limitation of alveolar-capillary diffusion nor an uneven ventilation-perfusion distribution, two factors that could cause an increase in . In addition, we assumed a constant lung volume during apnea, equal to published values of functional residual capacity, whereas it is known that lung volume can fall during apnea [@pcbi.1000588-Poets4],[@pcbi.1000588-Stark1]; based on our data, a fall in lung volume to 15.5 ml min^−1^kg^−1^ immediately after apnea onset would achieve of 4.3% s^−1^ ([Figure 5B](#pcbi-1000588-g005){ref-type="fig"}).

A final assumption implicit in our model is that all O~2~ transfer to the blood occurs via the pulmonary circulation. However, in very preterm infants there is evidence of percutaneous respiration in the first few days of life in both room air and with supplemental O~2~ [@pcbi.1000588-Cartlidge1]. With whole body exposure of 90% O~2~ to the newborn skin, it has been calculated that can be reduced by 8--10% [@pcbi.1000588-Cartlidge2], likely via an increased resting mixed-venous saturation; our study demonstrates that such an effect would decrease during apnea.

Pulmonary gas exchange dynamics during apnea {#s3b}
--------------------------------------------

Our study is consistent with previous observations that and rapidly decline during apnea from their steady-state values [@pcbi.1000588-Lanphier1], with falling faster than . The relatively low blood capacitance for O~2~ compared with that for CO~2~ results in the resting alveolar--mixed-venous partial pressure difference being ∼12-fold greater for O~2~ than for CO~2~. Consequently, when apnea begins ∼12 times more O~2~ than CO~2~ must diffuse across the lung to obliterate the alveolar--mixed-venous partial pressure difference. The slower fall in vs. provides for a faster depletion of alveolar O~2~ vs. CO~2~ stores; such an effect results in complete desaturation of arterial blood in the time rises by just 14 mmHg. These findings lead us to conclude that short-term O~2~ homeostasis is more unstable than CO~2~ homeostasis and thus that the danger of isolated apneas in infants is likely to be mediated via hypoxemia rather than hypercapnia.

Factors influencing {#s3c}
-------------------

Our study provides for the first time a comprehensive analysis of the factors that determine arterial desaturation during apnea in preterm infants. We show that resting oxygenation in the form of alveolar has the greatest influence on desaturation at apnea onset. When apnea begins at an increasingly lower alveolar , more quickly reaches its maximum because rapidly arrives at the steepest part of the O~2~-dissociation curve. This effect explains the inverse relationship between mean and pre-apneic during apnea [@pcbi.1000588-Strohl1], but as we show the peak slope itself is negligibly affected by reduced resting within the normal range.

We demonstrate that is inversely related to lung volume during stage 1 of apnea as a result of the greater reduction in alveolar in poorly inflated lungs per unit of O~2~ transferred into the pulmonary capillaries. This analysis is consistent with the inverse correlation between and lung volume [@pcbi.1000588-Poets4], with the view that active upper airway closure maintains lung volume and slows [@pcbi.1000588-Reix1],[@pcbi.1000588-Poets5], and with our recent report that the application of continuous positive airway pressure effectively slows in lambs [@pcbi.1000588-Edwards1]. However, once stage 2 begins, the blood becomes the principal source of O~2~ and thus the only store which influences .

A novel finding from our study is that reduced resting mixed-venous saturation, caused by either a reduced cardiac output or reduced hemoglobin content, strongly elevates peak , independent of metabolic O~2~ consumption. We show that reduced resting mixed-venous saturation accelerates via an increase in the peak value of ; in other words, low mixed-venous saturation provides for a greater pulmonary O~2~ uptake even in the presence of a developing arterial hypoxemia, and thereby increases . A role for hemoglobin in determining is consistent with the finding that elevated hemoglobin content in adults slows during apnea [@pcbi.1000588-Stewart1]. In contrast, blood transfusion to raise hemoglobin content in anemic preterm infants, a common clinical therapy, has little or no impact on the severity of apneic desaturation [@pcbi.1000588-Westkamp1]. Our proposed explanation for the lack of benefit of raising hemoglobin content via transfusion is that it also reduces heart rate [@pcbi.1000588-Westkamp1] and cardiac output. Thus, in the newborn, the rise in mixed-venous saturation expected after transfusion is counteracted by a tendency for mixed-venous saturation to fall as a result of reduced cardiac output. An investigation that failed to find an effect of cardiac output on [@pcbi.1000588-Fletcher2] did not account for our finding that pre-apneic and transient changes in cardiac output have opposing influence on . Importantly, we find that a transient fall in cardiac output, characteristic of bradycardia during apnea in preterm infants [@pcbi.1000588-Poets1], conserves alveolar O~2~ via reduced and thus reduces (see Equations 10 and 11). Consistent with this finding, apneic bradycardia prevents a rapid fall in in adults [@pcbi.1000588-Stewart1].

We found that each of the factors examined exerts a unique and therefore recognisable influence on the time course of the desaturation process ([Figure 10](#pcbi-1000588-g010){ref-type="fig"}). Low alveolar can be recognised by a left-shift of the desaturation trajectory so that desaturation begins sooner following the onset of apnea. A steep desaturation slope in the early phase of stage 1 points to a low ratio of lung volume to metabolic O~2~ consumption. In the late phase of stage 1, when desaturation proceeds in a linear fashion, a low resting mixed-venous saturation accelerates and leaves the fingerprint of a low inflection point in arterial O~2~ desaturation; low resting mixed-venous saturation reflects low cardiac output or hemoglobin content with respect to O~2~ consumption. Lastly rapid during stage 2 signifies a low total blood O~2~ capacity with respect to O~2~ consumption which would point to either low blood volume or anemia. The presence of a constant R-L shunt, while having no influence on , causes a parallel downwards shift in the desaturation trajectory. The unique impact of different factors on the desaturation curve may be used to guide preventive clinical intervention.

![Conceptual framework depicting the temporal sequence of influence of the key cardiorespiratory factors on .\
Note the regions of influence of lung volume (), cardiac output () and blood volume (), each with respect to metabolic O~2~ consumption (). Hemoglobin content (Hb) influences the latter phase of stage 1 as well as stage 2. The impact of reduced is limited to stage 1, and blood volume to stage 2. Reduced causes a leftward shift in the desaturation trajectory. Note that the point of inflection at the transition between stages reveals the resting .](pcbi.1000588.g010){#pcbi-1000588-g010}

Clinical significance {#s3d}
---------------------

We show theoretically that the lower lung volume [@pcbi.1000588-Hjalmarson1] and higher metabolic O~2~ consumption [@pcbi.1000588-Olhager1] of preterm compared to term infants predisposes to a rapid onset and progression of desaturation during apnea. Two reports offer support for this view. First, rapid desaturation occurs in infants with low functional residual capacity [@pcbi.1000588-Poets4], a finding that may help to explain the more frequent O~2~ desaturation events during active sleep [@pcbi.1000588-Tourneux1] when functional residual capacity is reduced. Second, frequent desaturation is characteristic of preterm infants with bronchopulmonary dysplasia (BPD) [@pcbi.1000588-Sekar1] whose O~2~ consumption is 25% greater [@pcbi.1000588-Weinstein1], and functional residual capacity is 25% less [@pcbi.1000588-Hjalmarson2], than in preterm infants without BPD; Equations 11 and 12 predict that such differences increase both immediate and peak by ∼70%. In addition, hypoventilation and reduced resting in infants with BPD, as inferred from elevated [@pcbi.1000588-Kaempf1], further increase desaturation at apnea onset. Our finding that each rise of 1% in inspired O~2~ provides ∼1 s of delay (right-shift) in the onset of apneic desaturation (Equation 15) may guide the titration of supplemental O~2~ for the prevention of apneic hypoxemia while minimising the well known side-effects of long-term exposure to hyperoxia.

Our study has implications for the management of infants in clinical care. Metabolic O~2~ consumption can be elevated after feeding [@pcbi.1000588-Dechert1], with reduced ambient temperature [@pcbi.1000588-Hey1], and via the adminstration of methylxanthines [@pcbi.1000588-Bauer1]. Despite the success of methylxanthines in reducing the frequency of apnea and bradycardia, such treatment has surprisingly little impact on hypoxemic episodes [@pcbi.1000588-Bucher1]; we suggest that the elevated O~2~ consumption and the absence of bradycardia are likely to increase during those apneas that persist despite treatment. The severity of hypoxemic episodes is reduced by switching preterm infants from supine to prone [@pcbi.1000588-McEvoy1], which may increase functional residual capacity [@pcbi.1000588-Kassim1] and improve diaphragm function, increase tidal volume and increase resting alveolar [@pcbi.1000588-Wagaman1]. Our finding that low cardiac output leads to increased during apnea leads to the suggestion that judicious adjustment of inotropic support in infants with cardiac abnormalities could improve resting mixed-venous saturation and reduce apneic hypoxemia.

Hypoxemic events become less frequent between infancy and childhood, despite an unchanged apnea frequency [@pcbi.1000588-Poets5], perhaps as a result of a fall in O~2~ consumption per body weight. However, before this occurs, infants experience a period of susceptibility to rapid desaturation during apnea as a result of a fall in hemoglobin content and O~2~ affinity [@pcbi.1000588-DelivoriaPapadopoulos1] and a rise in O~2~ consumption [@pcbi.1000588-Hill1]. The implications for SIDS are obvious in that these changes coincide with the peak incidence for SIDS at 2--3 months [@pcbi.1000588-Blair1]. SIDS also occurs disproportionately in preterm infants [@pcbi.1000588-Blair1], who manifest severe anemia [@pcbi.1000588-DelivoriaPapadopoulos1] and greater O~2~ consumption. Infants resuscitated from apparent life threatening events have been found to have lower hemoglobin content [@pcbi.1000588-Poets6], pointing to a potential role for rapid in the progression of such events. It is possible that the rapid development of apneic hypoxemia initiates prolonged hypoxic cardiorespiratory depression that in turn leads to SIDS.

Conclusion {#s3e}
----------

We have provided a mathematical framework for quantifying the relative importance of key cardiorespiratory factors on the rate of arterial O~2~ desaturation during apnea, with particular relevance to preterm infants. For the first time we have demonstrated that each of the factors examined has a signature influence on the trajectory of desaturation, providing quantitative insight into the causes of rapidly developing hypoxemia during apnea.

Methods {#s4}
=======

Mathematical model {#s4a}
------------------

### Lung compartment {#s4a1}

For the lung, a single homogeneous compartment is assumed based on the model of Grodins et al [@pcbi.1000588-Grodins1]. Each equation describing changes in the alveolar partial pressure of each gas (G) is based on the conservation of mass (specifically, the pressure--volume product) and is expressed in terms of inspired and expired alveolar ventilation and transfer of gases into the pulmonary capillary:where represents the rate of change of alveolar , , and ; represents the inspired alveolar partial pressure of each gas G; P~0~ is atmospheric pressure converted from STP to BTP (863 mmHg); represents and , pulmonary gas uptake (STPD) for O~2~ and CO~2~ ( was neglected in this study for simplicity); and are inspired and expired alveolar ventilation (BTPS). Accounting for the difference in and due to a net pulmonary gas uptake into the pulmonary blood, yields:where  = barometric pressure (760 mmHg);  = water vapour pressure (47 mmHg); is the net pulmonary gas uptake, .

Since purely obstructive apneas are relatively rare in preterm infants [@pcbi.1000588-Milner1], an unobstructed airway was chosen as the standard model in this study. In the current study it was assumed that lung volume did not fall during apnea, as in active sleep [@pcbi.1000588-Stark1], when apneic desaturation events are most common [@pcbi.1000588-Tourneux1]. With lung volume constant, conservation of mass requires that passive airflow into the unobstructed airway must occur in response to a net pulmonary gas uptake into the pulmonary blood [@pcbi.1000588-Lanphier1]. To account for this effect, we can write:Pilot simulations predicted that the volume of gas inflow during apnea is unlikely to exceed physiological deadspace. Thus, during apnea is taken as of the last exhaled breath prior to apnea onset.

For the current study we assumed diffusion equilibrium at the pulmonary capillaries, such that . Gas uptake is determined from the Fick equation; specifically, pulmonary blood flow (), and the difference between end capillary () and mixed venous () content:Utilising equations for R-L shunt, arterial content of each gas G is determined from its end capillary () and mixed venous () content, and pulmonary shunt fraction ():Fs defines the ratio of pulmonary blood flow to cardiac output, such that Fs = .

### Body compartment {#s4a2}

Assuming that the of the venous blood is equilibrated with the tissue , the mass-balance equations are:where represents the gas content of O~2~ and CO~2~ in the arterioles; T~a~ is arterial transit time; represents and , the metabolic consumption of O~2~ and production of CO~2~; represents and the combined venous/tissue volumes for O~2~ and CO~2~.

Blood O~2~ stores were partitioned by assigning blood volume (Qb) to arterial (25%) and venous (75%) compartments [@pcbi.1000588-Guyton1] and they were modelled assuming an entirely unmixed arterial compartment, and an entirely mixed and homogenous venous compartment. The arterial transit time (T~a~) is constrained by the arterial volume (Qa) by the relationship . The body compartment volume is taken as the venous volume. , the effective venous/tissue volume for CO~2~ is taken as the same value for Qv~O~2~~, based on published data (see [Methods](#s4){ref-type="sec"} -- Derivation of equations). Physiologically this represents no additional contribution of a specific tissue reservoir for CO~2~ within the time frame of apnea.

To characterise the O~2~-dissociation curve we used a modified form of the equation of Severinghaus [@pcbi.1000588-Severinghaus1]. We re-expressed the equation with respect to the partial pressure at 50% (P~50~) and at 90% (P~90~) saturation:where and . Values for P~50~ (24.0 mmHg) and P~90~ (53.6 mmHg), were obtained from the data of Delivoria-Papadopoulos [@pcbi.1000588-DelivoriaPapadopoulos1] for a 9--10 wk-old preterm infant. O~2~ content (, ml ml^−1^) includes that bound to hemoglobin (Hb, g ml^−1^) and that dissolved in plasma:The relationship between CO~2~ content () and was assumed linear:where and as adapted for STPD from Grodins et al. [@pcbi.1000588-Grodins2].

Simulations were performed using software written in MATLAB (The Mathworks; Natick, MA).

Theory {#s4b}
------

### A general equation {#s4b1}

In an earlier study we developed a general relationship that describes the factors influencing the magnitude of at any instant in time during apnea [@pcbi.1000588-Wilkinson1]:where is the capacitance co-efficient of blood for O~2~. To specifically demonstrate the role of gas exchange, it is more useful to represent in terms of . Using Equation 1 for O~2~ under conditions of apnea (,), assuming , and using , reveals:where (% mmHg^−1^) is defined as the slope of the O~2~-dissociation curve, specifically regarding end-capillary with respect to . It is clear from Equation 11 that is directly proportional to the product , which both vary substantially during apneic arterial desaturation. Although Equations 10 and 11 are useful conceptually, values for () or throughout apnea are unknown, and thus is not simple to predict explicitly.

### Special cases {#s4b2}

The original framework to understand factors influencing was based on the assumption that [@pcbi.1000588-Fletcher1],[@pcbi.1000588-Fletcher2] which does not hold true during apnea [@pcbi.1000588-Lanphier1],[@pcbi.1000588-Wilkinson1]. However, such an assumption is valid prior to any substantial fall in , and as therefore useful to explicitly describe immediately upon apnea onset ():Notably, Equation 12 demonstrates that for any level of and , is intimately related to . Consequently, increases dramatically with reduced resting ([Figure 11](#pcbi-1000588-g011){ref-type="fig"}).

![Relationship between the slope of the oxy-hemoglobin dissociation curve and alveolar .\
Note that reduced alveolar () causes a substantial increase in the slope of the oxy-hemoglobin dissociation curve (; see inset) and in at apnea onset (; based on Equation 12).](pcbi.1000588.g011){#pcbi-1000588-g011}

Although no simple expression could be written to describe explicitly for stage 1, we derived an expression for during stage 2 (see [Methods](#s4){ref-type="sec"} -- Derivation of equations), given by:Since the total blood O~2~ capacity () is much greater than , is determined principally by () with negligible influence coming from lung volume () and the slope of the O~2~-dissociation curve (), as well as . Using the values for the preterm infant in [Table 2](#pcbi-1000588-t002){ref-type="table"} and maximum , Equation 13 predicts that . The little remaining during stage 2 can be found by combining Equations 11 and 13:Equation 14 predicts that of its resting value during stage 2. Notably, is increased by reducing Hb and Qb; the greater and thus a greater rate of alveolar O~2~ depletion with reduced blood O~2~ capacity () will increase .

How can we reconcile that Equation 13 shows that no longer influences during stage 2, when the general equation (Equation 11) implies that reduced will accelerate throughout apneic desaturation? Equation 14 reveals that during stage 2, elevated also acts to increase ; thus nearly entirely offsetting the direct influence on . The same applies for reduced , which acts to elevate and therefore no longer accelerates during stage 2.

Derivation of equations {#s4c}
-----------------------

Here we derive the explicit equations used within the current study to encapsulate key relationships pertaining to gas exchange and arterial desaturation during apnea.

### Stage 2 arterial O~2~ desaturation {#s4c1}

This section details the derivation of an explicit equation to predict the rate of both arterial and venous desaturation during the severe desaturation of stage 2, a phase where is substantially reduced below and both and fall at the same rate. Ignoring dissolved plasma O~2~, consideration of Equation 1 for O~2~ and assuming yields:

By substituting the following relationships into Equation 15: ; ; Qb = Qa+Qv; ; it can be shown that is directly proportional to the difference between and , where:Combining Equations 11 and 16 yields Equation 13.

### Estimation of effective blood volume for CO~2~ {#s4c2}

Using the same methodology as described above, the ratio of to during stage 2 can be used to estimate the ratio of to . and can be found using:where and are the effective blood volumes for O~2~/CO~2~; is the capacitance coefficient for CO~2~. Neglecting pulmonary gas exchange, combining Equation 17 for O~2~ and CO~2~ gives:Equation 18 permitted the calculation of based on published data [@pcbi.1000588-Hong1] where during apnea the rate of rise in is very close to the rate of fall in the product of and the respiratory exchange ratio (RER); using from their data, and assuming resting RER = 0.8, we find that or approximately 1. Thus is assumed to be 1.

### Stage 1 hypercapnia {#s4c3}

Here we develop a relationship to describe the time-course of alveolar/arterial hypercapnia during stage 1 for CO~2~. Using Equation 1 for CO~2~, taking ,, gives the relationship . Substituting the steady-state Fick equation, , assuming alveolar-arterial equilibrium (), using under resting conditions, assuming that is constant, and solving for yields:Calculating the rate of rise in () by taking the derivative gives:

Equations 19 and 20 describe the slowing of from the initial rate as rises towards . Specifically, the time constant demonstrates that high causes a rapid slowing of and hence of as the arterial value approaches venous value. Indeed, fitting an exponential curve to the trace ([Figure 2](#pcbi-1000588-g002){ref-type="fig"}) during the first 5 s of apnea yielded a rapid time constant of 1.26 s, a value close to that predicted by . The corollary is that the low value of prevents the slowing of as desaturation progresses, giving rise to a rapid decline and thus rapid arterial desaturation. Likewise, further reducing by lowering hemoglobin content potentiates such effect.

### Impact of supplemental O~2~ {#s4c4}

The delay (right-shift) in arterial desaturation during apnea with increasing supplemental O~2~ () can be predicted explicitly. Using Equation 1 for O~2~ under the conditions of apnea, and assuming , the delay () in arterial desaturation is given by:

The authors have declared that no competing interests exist.

We received no funding for this work.

[^1]: Conceived and designed the experiments: SAS PJB. Performed the experiments: SAS. Analyzed the data: SAS BAE MRD MHW PJB. Wrote the paper: SAS BAE VJK MRD MHW PJB. Designed and implemented the model: SAS VJK MRD MHW.
